CME Group Inc.
CME
$276.29
$2.290.84%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.92% | 8.50% | 11.94% | 9.71% | 9.12% |
| Total Other Revenue | 24.12% | 33.13% | 31.59% | 27.75% | 25.77% |
| Total Revenue | 11.73% | 9.90% | 13.05% | 10.72% | 10.02% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 11.73% | 9.90% | 13.05% | 10.72% | 10.02% |
| SG&A Expenses | 4.90% | 4.84% | 6.12% | 4.69% | 5.77% |
| Depreciation & Amortization | -4.35% | -4.48% | -4.82% | -4.04% | -2.84% |
| Other Operating Expenses | 8.46% | 6.70% | -10.47% | -8.06% | -5.74% |
| Total Operating Expenses | 3.68% | 3.45% | 2.56% | 1.94% | 3.15% |
| Operating Income | 16.58% | 13.83% | 19.91% | 16.53% | 14.62% |
| Income Before Tax | 13.69% | 9.34% | 11.97% | 9.47% | 10.16% |
| Income Tax Expenses | 14.63% | 9.51% | 6.44% | 4.80% | 5.24% |
| Earnings from Continuing Operations | 13.42% | 9.29% | 13.65% | 10.89% | 11.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 13.42% | 9.29% | 13.65% | 10.89% | 11.66% |
| EBIT | 16.58% | 13.83% | 19.91% | 16.53% | 14.62% |
| EBITDA | 14.68% | 12.14% | 17.45% | 14.42% | 12.78% |
| EPS Basic | 13.31% | 9.17% | 13.53% | 10.78% | 11.56% |
| Normalized Basic EPS | 13.35% | 9.00% | 11.86% | 9.37% | 10.07% |
| EPS Diluted | 13.11% | 9.04% | 13.41% | 10.67% | 11.59% |
| Normalized Diluted EPS | 13.34% | 8.99% | 11.83% | 9.34% | 10.05% |
| Average Basic Shares Outstanding | 0.10% | 0.10% | 0.10% | 0.09% | 0.09% |
| Average Diluted Shares Outstanding | 0.11% | 0.12% | 0.13% | 0.12% | 0.11% |
| Dividend Per Share | 5.62% | 4.55% | 5.81% | 7.14% | 8.54% |
| Payout Ratio | -0.04% | 0.01% | -0.02% | 0.01% | 0.01% |